Green Alpha Advisors’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $700K | Buy |
551,445
+187,121
| +51% | +$292K | 0.47% | 60 |
|
|
2026
Q2 | $641K | Sell |
364,324
-9,326
| -2% | -$18.4K | 0.43% | 56 |
|
|
2026
Q1 | $710K | Sell |
373,650
-1,489
| -0.4% | -$2.56K | 0.7% | 37 |
|
|
2025
Q4 | $596K | Buy |
375,139
+11,440
| +3% | +$24K | 0.55% | 60 |
|
|
2025
Q3 | $847K | Sell |
363,699
-61,980
| -15% | -$117K | 0.82% | 40 |
|
|
2025
Q2 | $536K | Sell |
425,679
-6,646
| -2% | -$6.54K | 0.51% | 62 |
|
|
2025
Q1 | $395K | Buy |
432,325
+251,271
| +139% | +$327K | 0.42% | 72 |
|
|
2024
Q4 | $288K | Buy |
181,054
+77,840
| +75% | +$157K | 0.23% | 115 |
|
|
2024
Q3 | $202K | Buy |
103,214
+25,843
| +33% | +$52.9K | 0.16% | 122 |
|
|
2024
Q2 | $127K | Sell |
77,371
-6,150
| -7% | -$19.7K | 0.1% | 130 |
|
|
2024
Q1 | $429K | Buy |
83,521
+3,957
| +5% | +$24.4K | 0.31% | 107 |
|
|
2023
Q4 | $456K | Sell |
79,564
-30,960
| -28% | -$153K | 0.33% | 112 |
|
|
2023
Q3 | $528K | Buy |
110,524
+4,698
| +4% | +$29.1K | 0.41% | 91 |
|
|
2023
Q2 | $450K | Buy |
105,826
+21,359
| +25% | +$96K | 0.3% | 114 |
|
|
2023
Q1 | $449K | Buy |
84,467
+9,360
| +12% | +$58.3K | 0.31% | 111 |
|
|
2022
Q4 | $472K | Buy |
75,107
+5,731
| +8% | +$51K | 0.39% | 102 |
|
|
2022
Q3 | $732K | Sell |
69,376
-182,896
| -72% | -$1.7M | 0.62% | 71 |
|
|
2022
Q2 | $1.37M | Buy |
252,272
+202,598
| +408% | +$1.55M | 0.31% | 64 |
|
|
2022
Q1 | $456K | Buy |
49,674
+14,082
| +40% | +$148K | 0.31% | 110 |
|
|
2021
Q4 | $537K | Buy |
35,592
+2,756
| +8% | +$53.6K | 0.36% | 105 |
|
|
2021
Q3 | $784K | Buy |
+32,836
| New | +$803K | 0.54% | 96 |
|
Other funds holding CRBU
Green Alpha Advisors's CRBU Position: Q3 2026 in Review
Green Alpha Advisors increased its Caribou Biosciences (CRBU) stake by 51% in Q3 2026, buying an estimated $292K and bringing the position to 551,445 shares worth $700K. The position accounts for 0.47% of the portfolio, ranked #60.
Green Alpha Advisors first reported a position in CRBU in Q3 2021 and has held it in 21 quarters since. The position peaked at $1.37M in Q2 2022. 3 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.
- Green Alpha Advisors held 551,445 shares of Caribou Biosciences worth $700K as of Q3 2026.
- Green Alpha Advisors bought 187,121 Caribou Biosciences shares in Q3 2026, an estimated $292K.
- Caribou Biosciences made up 0.47% of Green Alpha Advisors's portfolio in Q3 2026, its #60 holding.
- Green Alpha Advisors first reported a position in Caribou Biosciences in Q3 2021 and has held it in 21 quarters since.
- Green Alpha Advisors's Caribou Biosciences position peaked at $1.37M in Q2 2022.
- 3 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.
Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.